AVEAX
Price
$15.72
Change
-$0.15 (-0.95%)
Updated
Jan 22 closing price
Net Assets
59.83M
GAFFX
Price
$78.43
Change
+$0.54 (+0.69%)
Updated
Jan 22 closing price
Net Assets
310.06B
Ad is loading...

AVEAX vs GAFFX

Header iconAVEAX vs GAFFX Comparison
Open Charts AVEAX vs GAFFXBanner chart's image
Ave Maria Focused
Price$15.72
Change-$0.15 (-0.95%)
VolumeN/A
Net Assets59.83M
American Funds Growth Fund of Amer F3
Price$78.43
Change+$0.54 (+0.69%)
VolumeN/A
Net Assets310.06B
AVEAX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVEAX vs. GAFFX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVEAX is a Buy and GAFFX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 310B vs. AVEAX (59.8M). GAFFX pays higher dividends than AVEAX: GAFFX (0.75) vs AVEAX (0.00). AVEAX was incepted earlier than GAFFX: AVEAX (5 years) vs GAFFX (8 years). GAFFX is a more actively managed with annual turnover of: 31.00 vs. AVEAX (29.00). AVEAX has a lower initial minimum investment than GAFFX: AVEAX (2500) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 22.88 vs. AVEAX (18.64).
AVEAXGAFFXAVEAX / GAFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years8 years-
Gain YTD2.7455.31852%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets59.8M310B0%
Annual Yield % from dividends0.000.75-
Returns for 1 year18.6422.8881%
Returns for 3 years21.4822.1297%
Returns for 5 yearsN/A51.67-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WIT3.660.14
+3.98%
Wipro Limited
MTA2.65-0.02
-0.75%
Metalla Royalty & Streaming Ltd
GTES20.52-0.42
-2.01%
Gates Industrial Corp
BIVI2.00-0.05
-2.44%
BioVie Inc
RCUS13.40-0.74
-5.23%
Arcus Biosciences